Friday 6 November 2026 Export WST’s income statement to Excel — free account

West Pharmaceutical Services, Inc.

WST Healthcare Medical Instruments & Supplies

West Pharmaceutical Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $3.1 billion, up 6.25% from fiscal 2024.

Revenue: +8.69%
EPS: +56.7%
Free cash flow: +12.3%
Total debt: +0.10%

Quarter to September 2026, against a year earlier

392.97 15.81 −3.87%

Follow WST

Alert me

Market cap: $27.3B
P/E: 43.8×
Fwd P/E: 48.1×
Dividend yield: 0.22%
F-score: 8/9
Altman Z: 13.89
Beneish M: −2.79
Dividend safety: 100/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	40.28	33.33	45.62	41.33
P/S ratio Full definition →		6.47	5.60	7.64	7.68
P/FCF ratio Full definition →		42.77	39.73	58.69	58.05
P/Operating CF Full definition →		79.22	200.74	204.98	137.74
P/B ratio Full definition →		6.26	6.03	8.50	8.79
Price to Tangible BV Full definition →		6.50	6.28	8.84	9.15
EV/Sales Full definition →		6.28	5.50	7.57	7.61
EV/EBITDA Full definition →		25.52	21.32	29.22	26.79
EV/Operating CF Full definition →		25.58	24.78	38.03	39.48
EV/FCF Full definition →		41.51	39.03	58.15	57.47
Quick Ratio Full definition →		2.09	1.79	1.79	1.88
Current Ratio Full definition →		3.02	2.71	2.82	2.82
Net Debt/EBITDA Full definition →		(2.89)	(1.43)	(1.03)	(0.83)
Debt/Assets Full definition →		4.75%	4.93%	4.98%	5.00%
Debt/Equity Full definition →		0.06	0.07	0.07	0.07
Asset Turnover Full definition →		0.78	0.83	0.83	0.83
Operating CF/Net income Full definition →		1.90	0.65	0.81	0.89
Capex/Depreciation Full definition →		(1.62)	(0.94)	(0.94)	(0.85)
Interest Coverage Full definition →		(783.00)	93.21	68.88	70.37
Research and Development Expense of Revenue Full definition →		2.71%	1.87%	2.26%	2.09%
Selling, General and Administrative Expense of Revenue Full definition →		13.29%	11.78%	13.48%	12.91%
Intangible Assets out of Total Assets Full definition →		0.03	0.03	0.03	0.03
Share Based Compensation of Revenue Full definition →		0.83%	0.78%	1.25%	0.49%
Graham Net Nets Full definition →		0.04	0.04	0.03	0.03
Graham Number Full definition →		82.16	83.83	86.48	92.25
Earnings Yield Full definition →		2.48%	3.00%	2.19%	2.42%
Free Cash Flow Yield Full definition →		2.34%	2.52%	1.70%	1.72%
Revenue per Share Full definition →		11.13	11.73	12.32	12.42
Operating CF per Share Full definition →		3.47	1.25	1.75	2.69
Capex per Share Full definition →		(1.05)	(0.59)	(0.61)	(0.56)
Free Cash Flow per Share Full definition →		2.42	0.66	1.14	2.14
Cash per Share Full definition →		10.94	7.24	6.16	6.59
Shareholders Equity per Share Full definition →		43.93	41.53	42.23	42.16
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		43.93	41.53	42.23	42.16
Free Cash Flow Full definition →		175.00	47.20	80.80	150.40
Working Capital Full definition →		1,323.30	1,152.80	1,167.00	1,172.20
Capital Expenditures Full definition →		(76.10)	(42.70)	(43.20)	(39.10)
Net Current Asset Value Full definition →		884.20	707.40	721.30	724.00
EV/EBIT Full definition →		33.00	27.06	37.01	33.12
Capex to Sales Full definition →		0.09	0.05	0.05	0.04
Price to Operating Income Full definition →		34.01	27.55	37.36	33.45
Other line items
Average Receivables Full definition →		563.45	614.60	647.20	686.60
Average Payables Full definition →		246.50	240.35	245.85	252.60
Average Inventory Full definition →		410.45	420.65	434.25	451.35
Average Assets Full definition →		3,956.70	3,864.00	4,014.60	4,083.25
Average Common Equity Full definition →		2,929.15	2,836.75	2,959.65	3,009.85

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly